These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34134990)

  • 1. Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs.
    Park JH; Jiang Y; Zhou J; Gong H; Mohapatra A; Heo J; Gao W; Fang RH; Zhang L
    Sci Adv; 2021 Jun; 7(25):. PubMed ID: 34134990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of mZD7349-conjugated PLGA nanoparticles for selective targeting of vascular cell-adhesion molecule-1 in inflamed endothelium.
    Imanparast F; Paknejad M; Faramarzi MA; Kobarfard F; Amani A; Doosti M
    Microvasc Res; 2016 Jul; 106():110-6. PubMed ID: 27105996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers.
    Klemke M; Weschenfelder T; Konstandin MH; Samstag Y
    J Cell Physiol; 2007 Aug; 212(2):368-74. PubMed ID: 17352405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-α enhanced fusions between oral squamous cell carcinoma cells and endothelial cells via VCAM-1/VLA-4 pathway.
    Song K; Zhu F; Zhang HZ; Shang ZJ
    Exp Cell Res; 2012 Aug; 318(14):1707-15. PubMed ID: 22664325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VCAM-1-targeted core/shell nanoparticles for selective adhesion and delivery to endothelial cells with lipopolysaccharide-induced inflammation under shear flow and cellular magnetic resonance imaging in vitro.
    Yang H; Zhao F; Li Y; Xu M; Li L; Wu C; Miyoshi H; Liu Y
    Int J Nanomedicine; 2013; 8():1897-906. PubMed ID: 23696701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor.
    Gorelik M; Orukari I; Wang J; Galpoththawela S; Kim H; Levy M; Gilad AA; Bar-Shir A; Kerr DA; Levchenko A; Bulte JW; Walczak P
    Radiology; 2012 Oct; 265(1):175-85. PubMed ID: 22923719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-targeted delivery of dexamethasone by anti-VCAM-1 SAINT-O-Somes in mouse endotoxemia.
    Li R; Kowalski PS; Morselt HWM; Schepel I; Jongman RM; Aslan A; Ruiters MHJ; Zijlstra JG; Molema G; van Meurs M; Kamps JAAM
    PLoS One; 2018; 13(5):e0196976. PubMed ID: 29763440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell-targeting, ROS-ultrasensitive drug/siRNA co-delivery nanocomplexes mitigate early-stage neutrophil recruitment for the anti-inflammatory treatment of myocardial ischemia reperfusion injury.
    Hou M; Wu X; Zhao Z; Deng Q; Chen Y; Yin L
    Acta Biomater; 2022 Apr; 143():344-355. PubMed ID: 35189380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity very late antigen-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow.
    Chen C; Mobley JL; Dwir O; Shimron F; Grabovsky V; Lobb RR; Shimizu Y; Alon R
    J Immunol; 1999 Jan; 162(2):1084-95. PubMed ID: 9916737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators released from LPS-challenged lungs induce inflammatory responses in liver vascular endothelial cells and neutrophilic leukocytes.
    Markovic N; McCaig LA; Stephen J; Mizuguchi S; Veldhuizen RA; Lewis JF; Cepinskas G
    Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1066-76. PubMed ID: 19815624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant adenoviral vector expressing a soluble form of VCAM-1 inhibits VCAM-1/VLA-4 adhesion in transduced synoviocytes.
    Chen SJ; Wilson JM; Vallance DK; Hartman JW; Davidson BL; Roessler BJ
    Gene Ther; 1995 Sep; 2(7):469-80. PubMed ID: 7584125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of divalent cations on the affinity and selectivity of alpha4 integrins towards the integrin ligands vascular cell adhesion molecule-1 and mucosal addressin cell adhesion molecule-1: Ca2+ activation of integrin alpha4beta1 confers a distinct ligand specificity.
    Day ES; Osborn L; Whitty A
    Cell Commun Adhes; 2002; 9(4):205-19. PubMed ID: 12699089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis.
    Chen Q; Massagué J
    Clin Cancer Res; 2012 Oct; 18(20):5520-5. PubMed ID: 22879387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions.
    Liang S; Dong C
    Am J Physiol Cell Physiol; 2008 Sep; 295(3):C701-7. PubMed ID: 18632734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro inhibitory effects of a traditional Chinese formulation on LPS-stimulated leukocyte-endothelial cell adhesion and VCAM-1 gene expression.
    Wu YH; Chuang SY; Hong WC; Lai YJ; Chang YL; Pang JH
    J Ethnopharmacol; 2012 Mar; 140(1):55-63. PubMed ID: 22226975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction affinity between vascular cell adhesion molecule-1 (VCAM-1) and very late antigen-4 (VLA-4) analyzed by quantitative FRET.
    Chakraborty S; Hu SY; Wu SH; Karmenyan A; Chiou A
    PLoS One; 2015; 10(3):e0121399. PubMed ID: 25793408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion.
    Vanderslice P; Biediger RJ; Woodside DG; Brown WS; Khounlo S; Warier ND; Gundlach CW; Caivano AR; Bornmann WG; Maxwell DS; McIntyre BW; Willerson JT; Dixon RA
    J Biol Chem; 2013 Jul; 288(27):19414-28. PubMed ID: 23703610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of beta 1 integrin intracytoplasmic domains in the regulation of VLA-4-mediated adhesion of human T cells to VCAM-1 under flow conditions.
    Rosenthal-Allieri MA; Ticchioni M; Breittmayer JP; Shimizu Y; Bernard A
    J Immunol; 2005 Jul; 175(2):1214-23. PubMed ID: 16002725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Allosteric Shift in CD11c Affinity Activates a Proatherogenic State in Arrested Intermediate Monocytes.
    Hernandez AA; Foster GA; Soderberg SR; Fernandez A; Reynolds MB; Orser MK; Bailey KA; Rogers JH; Singh GD; Wu H; Passerini AG; Simon SI
    J Immunol; 2020 Nov; 205(10):2806-2820. PubMed ID: 33055281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Talin 1 and paxillin facilitate distinct steps in rapid VLA-4-mediated adhesion strengthening to vascular cell adhesion molecule 1.
    Manevich E; Grabovsky V; Feigelson SW; Alon R
    J Biol Chem; 2007 Aug; 282(35):25338-48. PubMed ID: 17597073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.